Clonazepam

Product NDC
71335-2414
11-digit product format
713352414
Labeler code
71335
Product ID
71335-2414_29ea9247-b101-43e0-839b-1792e92ef0c4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Clonazepam
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA075468
Marketing category
ANDA
Marketing start
2022-04-14
Substance
CLONAZEPAM
Active strength
1 mg/1
Pharmacologic classes
Benzodiazepine [EPC], Benzodiazepines [CS]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data

Finished product
Yes
Brand name base
Clonazepam
Listing expiration
2026-12-31

Related Records

Active Ingredients

IngredientStrength
CLONAZEPAM1 mg/1

Harmonized Identifiers

FieldValues
Unii5PE9FDE8GB
Rxcui197528

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
5PE9FDE8GBCLONAZEPAM1622-61-3CLONAZEPAM

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
71335-2414-071335241400100 TABLET in 1 BOTTLE (71335-2414-0) 100 tablet2024-06-10NoNoCurrent
71335-2414-17133524140120 TABLET in 1 BOTTLE (71335-2414-1) 20 tablet2024-06-10NoNoCurrent
71335-2414-27133524140230 TABLET in 1 BOTTLE (71335-2414-2) 30 tablet2024-06-10NoNoCurrent
71335-2414-37133524140360 TABLET in 1 BOTTLE (71335-2414-3) 60 tablet2024-06-10NoNoCurrent
71335-2414-47133524140490 TABLET in 1 BOTTLE (71335-2414-4) 90 tablet2024-06-10NoNoCurrent
71335-2414-571335241405120 TABLET in 1 BOTTLE (71335-2414-5) 120 tablet2024-06-10NoNoCurrent
71335-2414-671335241406180 TABLET in 1 BOTTLE (71335-2414-6) 180 tablet2024-06-10NoNoCurrent
71335-2414-77133524140784 TABLET in 1 BOTTLE (71335-2414-7) 84 tablet2024-06-10NoNoCurrent
71335-2414-87133524140828 TABLET in 1 BOTTLE (71335-2414-8) 28 tablet2024-06-10NoNoCurrent
71335-2414-97133524140956 TABLET in 1 BOTTLE (71335-2414-9) 56 tablet2024-06-10NoNoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Clonazepam Tablets, USP Rx onlyBryant Ranch Prepack2025-08-25HUMAN PRESCRIPTION DRUG LABEL2